ROVUS Asia Registry (Evaluate Safety and Effectiveness of Rotational Atherectomy and Intravascular Ultrasound for Heavily Calcified Coronary Lesion)
Recruiting now
Conditions studied: Coronary Artery Calcification
In brief
Rotablation with or without other calcium debulking therapies is a safe adjunctive procedure for patients with severe coronary calcification requiring Percutaneous Coronary Intervention (PCI).
Key facts
- Study ID
- NCT04742478
- Run by
- National Heart Centre Singapore
- People needed
- 1000
- Starts
- 2021-03-10
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2021-04-23
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Able to understand and sign an informed consent form
- Presence of clinical indication for percutaneous coronary intervention (PCI) and/or stent placement
- Subjects willing to comply with all research and follow-up requirements.
- Angiographic criteria (ONE of the following criteria MUST be met)
- Target lesions visually have at least moderate calcifications*
- Target lesion balloon dilatation failure
- Inability of devices (microcatheters, balloons or stents) to pass through the target lesion.
- Procedural criteria
- All patients treated with RA with or without other forms of debulking therapy
- Moderate calcification is defined as radio-opacities noted only during cardiac cycle prior to contrast injection whereas severe calcification is defined as radio-opacities seen without cardiac motion prior to contrast injection, usually affecting both sides of the arterial lumen.
You may not qualify if…
- Decline to give consent
Where it is running
- Kokura Memorial hospital — Kitakyushu, Japan (enrolling)
- National Heart Centre Singapore — Singapore, Singapore (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.